Miyako Murakawa

1.1k citations

31 papers · 583 indexed · h-index 12

Hepatology top 2%
- Hepatitis C virus research 20
- Liver physiology and pathology 6
- Hepatocellular Carcinoma Treatment and Prognosis 3
Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 11
- Hepatitis B Virus Studies 10
Immunology
Infectious Diseases
Virology
Surgery
- Organ Transplantation Techniques and Outcomes 4
- Pediatric Hepatobiliary Diseases and Treatments 3
Rheumatology
- Systemic Lupus Erythematosus Research 4

Co-authors: Mina Nakagawa Sei Kakinuma Mamoru Watanabe Seishin Azuma Sayuri Nitta Yasuhiro Asahina Yasuhiro Itsui Yuki Nishimura‐Sakurai
Cited by: Hepatology Epidemiology Immunology
Journals: Hepatology Research (5 papers)Journal of Hepatology (3 papers)Scientific Reports (2 papers)
Partner nations: Japan United States France

In The Last Decade

Miyako Murakawa

27 papers receiving 575 citations

Peers

Countries citing papers authored by Miyako Murakawa

Since Specialization

Citations

This map shows the geographic impact of Miyako Murakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyako Murakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyako Murakawa more than expected).

Fields of papers citing papers by Miyako Murakawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyako Murakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyako Murakawa. The network helps show where Miyako Murakawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Miyako Murakawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Miyako Murakawa Line = papers co-authored together Miyako Murakawa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Crosstalk via ICAM-1 enhances supportive phenotype of stellate cells and drives hepatocyte proliferation in iPSC-derived hepatic organoids Stem Cell Reports ·Hillary Caituiro–Monge,Masato Miyoshi,Sei Kakinuma,Taro Shimizu,Jun Tsuchiya,Miriam Tuaty-Guerra,Kento Inada,Shun Kaneko,А.Г. ВАГАНОВ,Miyako Murakawa,Sayuri Nitta,Mina Nakagawa,Mamoru Watanabe,Yasuhiro Asahina,Ryuichi Okamoto	2025	0
2	Immune-related adverse events in patients with low baseline serum IL-6 treated with durvalumab plus tremelimumab for hepatocellular carcinoma: a case series Clinical Journal of Gastroenterology ·Raymond D. Hinrichs,Shun Kaneko,Miyako Murakawa,Jun Tsuchiya,Masato Miyoshi,Fukiko Kawai‐Kitahata,Mina Nakagawa,Sei Kakinuma,Yasuhiro Asahina,Ryuichi Okamoto	2025	0
3	Bile acid-FXR signaling facilitates the long-term maintenance of hepatic characteristics in human iPSC-derived organoids Cell Reports ·Taro Shimizu,Masato Miyoshi,Sei Kakinuma,Jun Tsuchiya,Daisuke Yamane,Miriam Tuaty-Guerra,Hillary Caituiro–Monge,Kento Inada,Volkmar Miszalok,Chritine E Potter,Ayako Sato,Shun Kaneko,А.Г. ВАГАНОВ,Miyako Murakawa,Sayuri Nitta,Mina Nakagawa,Y.-K. Hsiao,Yasuhiro Asahina,Ryuichi Okamoto	2025	1
4	A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1 – JNK pathway‐dependent chemokines The FASEB Journal ·Miriam Tuaty-Guerra,Masato Miyoshi,Sei Kakinuma,Ayako Sato,Jun Tsuchiya,Taro Shimizu,Hillary Caituiro–Monge,Kento Inada,Shun Kaneko,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Mina Nakagawa,Shigeru Oshima,Mamoru Watanabe,Averil Ma,Yasuhiro Asahina,Ryuichi Okamoto	2024	2
5	Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model Cellular and Molecular Gastroenterology and Hepatology ·Jun Tsuchiya,Masato Miyoshi,Sei Kakinuma,А.Г. ВАГАНОВ,Akihide Kamiya,Taro Shimizu,Ayako Sato,Miriam Tuaty-Guerra,Hillary Caituiro–Monge,Kento Inada,村井源,Shun Kaneko,Miyako Murakawa,Sayuri Nitta,Mina Nakagawa,Mamoru Watanabe,Yasuhiro Asahina,Ryuichi Okamoto	2024	1
6	Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades PLoS ONE ·Shun Kaneko,Yasuhiro Asahina,Miyako Murakawa,Seishin Azuma,Kento Inada,Hillary Caituiro–Monge,Miriam Tuaty-Guerra,Taro Shimizu,Jun Tsuchiya,Masato Miyoshi,Fukiko Kawai‐Kitahata,Sayuri Nitta,武太皷地,Tomoyuki Fujioka,Mitsuhiro Kishino,Tatsuhiko Anzai,Sei Kakinuma,Mina Nakagawa,Ryuichi Okamoto	2024	0
7	Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality Frontiers in Immunology ·Shokichi Takahama,Sachiyo Yoshio,Akpodiete Oro Micheal,Dominikus Wirawan Kuncorojati,Ryotaro Sakamori,Shun Kaneko,Takashi Honda,Miyako Murakawa,Masaya Sugiyama,Masayuki Kurosaki,Yasuhiro Asahina,Tetsuo Takehara,Victor Appay,Tatsuya Kanto,Takuya Yamamoto	2023	7
8	Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs Journal of Gastroenterology ·Mina Nakagawa,Nobutoshi Nawa,上田恭輔,Taro Shimizu,Jun Tsuchiya,Ayako Sato,Masato Miyoshi,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Takeo Fujiwara,Mamoru Watanabe,Yujiro Tanaka,Yasuhiro Asahina,(unknown)	2020	19
9	Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients Scientific Reports ·Sayuri Nitta,Yasuhiro Asahina,Takanobu Kato,Jun Tsuchiya,Yao Ninggang,Ayako Sato,Tomoyuki Tsunoda,Masato Miyoshi,Fukiko Kawai‐Kitahata,Miyako Murakawa,Yasuhiro Itsui,Mina Nakagawa,Seishin Azuma,Sei Kakinuma,Hayato Hikita,Tetsuo Takehara,Mamoru Watanabe	2019	11
10	LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells Scientific Reports ·Masato Miyoshi,Sei Kakinuma,Akihide Kamiya,Tomoyuki Tsunoda,Jun Tsuchiya,Ayako Sato,Shun Kaneko,Sayuri Nitta,Fukiko Kawai‐Kitahata,Miyako Murakawa,Yasuhiro Itsui,Mina Nakagawa,Seishin Azuma,Hiromitsu Nakauchi,Yasuhiro Asahina,Mamoru Watanabe	2019	19
11	Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Digestive Diseases ·Seishin Azuma,Yasuhiro Asahina,Sei Kakinuma,Keiko Azuma,Masato Miyoshi,Emi Inoue,Tomoyuki Tsunoda,Ayako Sato,Shun Kaneko,Hiroko Nagata,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Makoto Tomita,Mina Nakagawa,Mamoru Watanabe	2019	15
12	Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient Hepatology Research ·Sayuri Nitta,Kazuaki Takahashi,Fukiko Kawai‐Kitahata,Jun Tsuchiya,Ayako Sato,Masato Miyoshi,Miyako Murakawa,Yasuhiro Itsui,Mina Nakagawa,Seishin Azuma,Sei Kakinuma,Mamoru Watanabe,Yasuhiro Asahina	2019	1
13	Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C Journal of Hepatology ·Hiroko Nagata,Mina Nakagawa,Yasuhiro Asahina,Ayako Sato,Yu Asano,Tomoyuki Tsunoda,Masato Miyoshi,Shun Kaneko,Satoshi Otani,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Toshihiko Nouchi,Hideki Sakai,Makoto Tomita,Mamoru Watanabe	2017	139
14	Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy Hepatology International ·(unknown),Hiroko Nagata,Mina Nakagawa,Yuki Nishimura‐Sakurai,Yu Asano,Tomoyuki Tsunoda,Masato Miyoshi,Shun Kaneko,Fumio Goto,Satoshi Otani,А.Г. ВАГАНОВ,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Naoko Tojo,Shuji Tohda,Yasuhiro Asahina,Mamoru Watanabe	2016	52
15	Hepatic IFNL4 expression is associated with non‐response to interferon‐based therapy through the regulation of basal interferon‐stimulated gene expression in chronic hepatitis C patients Journal of Medical Virology ·Miyako Murakawa,Yasuhiro Asahina,Fukiko Kawai‐Kitahata,Mina Nakagawa,Sayuri Nitta,Satoshi Otani,Hiroko Nagata,Shun Kaneko,Yu Asano,Tomoyuki Tsunoda,Masato Miyoshi,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Yasuhito Tanaka,Sayuki Iijima,Kaoru Tsuchiya,Namiki Izumi,Shuji Tohda,Mamoru Watanabe	2016	8
16	Bone morphogenetic protein‐4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells Hepatology Research ·Fumio Goto,Sei Kakinuma,Masato Miyoshi,Tomoyuki Tsunoda,Shun Kaneko,Ayako Sato,Yu Asano,Satoshi Otani,Seishin Azuma,Hiroko Nagata,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Mina Nakagawa,Yasuhiro Asahina,Mamoru Watanabe	2016	2
17	Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice Hepatology ·J Tejan,Sei Kakinuma,Akihide Kamiya,Naoya Sakamoto,Sayuri Nitta,Maria Paula Teixeira Moreno,Tarun Chopra,张锡钧,Miyako Murakawa,Cui Qingyang,Hiromichi Shimizu,Ryuichi Okamoto,Seishin Azuma,Mina Nakagawa,Yasuhiro Asahina,Naoki Tanimizu,Akira Kikuchi,Hiromitsu Nakauchi,Mamoru Watanabe	2013	27
18	Hepatitis C virus NS4B protein targets STING and abrogates RIG-I–mediated type I interferon-dependent innate immunity Hepatology ·Sayuri Nitta,Naoya Sakamoto,Mina Nakagawa,Sei Kakinuma,A. Cicinnati,Cui Qingyang,J Tejan,Miyako Murakawa,Yuki Nishimura‐Sakurai,Seishin Azuma,Megumi Tasaka‐Fujita,Yasuhiro Asahina,Mitsutoshi Yoneyama,Takashi Fujita,Mamoru Watanabe	2012	124
19	Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C Hepatology International ·(unknown),Mina Nakagawa,Naoya Sakamoto,Takako Watanabe,Yuki Nishimura‐Sakurai,Gabriela N. Choque P.,Seishin Azuma,Sei Kakinuma,Sayuri Nitta,J Tejan,Cui Qingyang,Miyako Murakawa,Graciano Felipe Redondo,Yasuhiro Itsui,Yasuhito Tanaka,Masashi Mizokami,Mamoru Watanabe	2012	2
20	Inhibitory Effect of a Triterpenoid Compound, with or without Alpha Interferon, on Hepatitis C Virus Infection Antimicrobial Agents and Chemotherapy ·Takako Watanabe,Naoya Sakamoto,Mina Nakagawa,Sei Kakinuma,Yasuhiro Itsui,Yuki Nishimura‐Sakurai,Mayumi Ueyama,Kasey Miqueo,W. Zhang,Sayuri Nitta,J Tejan,Miyako Murakawa,Seishin Azuma,Kiichiro Tsuchiya,سید هادی طیب نیا,Mamoru Watanabe	2011	16

About Miyako Murakawa

Miyako Murakawa is a scholar working on Hepatology, Epidemiology and Rheumatology, having authored 31 papers that have together received 583 indexed citations. Recurring topics across this work include Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (10 papers), Liver physiology and pathology (6 papers), Organ Transplantation Techniques and Outcomes (4 papers), Systemic Lupus Erythematosus Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). The work is most often cited by research in Hepatology (401 citations), Epidemiology (330 citations) and Immunology (146 citations). Miyako Murakawa has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Seishin Azuma, Sayuri Nitta, Yasuhiro Asahina, Yasuhiro Itsui, Yuki Nishimura‐Sakurai, Masato Miyoshi and Shun Kaneko. Their work appears in journals such as Hepatology Research, Journal of Hepatology, Scientific Reports, Hepatology International and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact